Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Immunological Methods
|
January 21, 2014
Mouse models for dengue vaccines and antivirals
Emily M Plummer, Sujan Shresta
Molecular Pharmaceutics
|
August 22, 2012
Endocytic uptake pathways utilized by CPMV nanoparticles
Emily M Plummer, Marianne Manchester
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|
September 28, 2010
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
Emily M Plummer, Marianne Manchester
Plos One
|
December 4, 2009
Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo
Maria J Gonzalez, Emily M Plummer, Chris S Rae, et al.
Nanomedicine (London, England)
|
March 8, 2012
Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions
Emily M Plummer, Diane Thomas, Giuseppe Destito, et al.
Journal of Materials Chemistry. B
|
April 9, 2020
Localization of gadolinium-loaded CPMV to sites of inflammation during central nervous system autoimmunity
Leah P Shriver, Emily M Plummer, Diane M Thomas, et al.
Plos Pathogens
|
May 5, 2009
Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin
Kristopher J Koudelka, Giuseppe Destito, Emily M Plummer, et al.
Journal of Virology
|
August 31, 2012
Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice
Tyler R Prestwood, Monica M May, Emily M Plummer, et al.
Journal of Lipid Research
|
March 22, 2018
FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver
Romeo Papazyan, Xueqing Liu, Jingwen Liu, et al.
Scientific Reports
|
July 30, 2015
Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
Seleeke Flingai, Emily M Plummer, Ami Patel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Immunological Methods
|
January 21, 2014
Mouse models for dengue vaccines and antivirals
Emily M Plummer, Sujan Shresta
Molecular Pharmaceutics
|
August 22, 2012
Endocytic uptake pathways utilized by CPMV nanoparticles
Emily M Plummer, Marianne Manchester
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|
September 28, 2010
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
Emily M Plummer, Marianne Manchester
Plos One
|
December 4, 2009
Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo
Maria J Gonzalez, Emily M Plummer, Chris S Rae, et al.
Nanomedicine (London, England)
|
March 8, 2012
Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions
Emily M Plummer, Diane Thomas, Giuseppe Destito, et al.
Journal of Materials Chemistry. B
|
April 9, 2020
Localization of gadolinium-loaded CPMV to sites of inflammation during central nervous system autoimmunity
Leah P Shriver, Emily M Plummer, Diane M Thomas, et al.
Plos Pathogens
|
May 5, 2009
Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin
Kristopher J Koudelka, Giuseppe Destito, Emily M Plummer, et al.
Journal of Virology
|
August 31, 2012
Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice
Tyler R Prestwood, Monica M May, Emily M Plummer, et al.
Journal of Lipid Research
|
March 22, 2018
FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver
Romeo Papazyan, Xueqing Liu, Jingwen Liu, et al.
Scientific Reports
|
July 30, 2015
Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
Seleeke Flingai, Emily M Plummer, Ami Patel, et al.
Page
of 2